Merck KGaA (MKKGY)
32.33
+0.07
(+0.22%)
USD |
OTCM |
Sep 01, 16:00
Merck Free Cash Flow : 38.93M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 38.93M |
| March 31, 2026 | 371.41M |
| December 31, 2025 | 415.78M |
| September 30, 2025 | 369.40M |
| June 30, 2025 | -856.41M |
| March 31, 2025 | -218.88M |
| December 31, 2024 | 164.21M |
| September 30, 2024 | 577.71M |
| June 30, 2024 | 1.434B |
| March 31, 2024 | 27.94M |
| December 31, 2023 | -787.22M |
| September 30, 2023 | -1.555B |
| June 30, 2023 | -629.03M |
| March 31, 2023 | 418.35M |
| December 31, 2022 | 1.436B |
| September 30, 2022 | 2.347B |
| June 30, 2022 | 2.338B |
| March 31, 2022 | 3.023B |
| December 31, 2021 | 3.780B |
| September 30, 2021 | 3.619B |
| June 30, 2021 | 3.505B |
| March 31, 2021 | 3.047B |
| December 31, 2020 | 2.191B |
| September 30, 2020 | 1.835B |
| June 30, 2020 | 1.626B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.902B |
| December 31, 2019 | 2.042B |
| September 30, 2019 | 2.146B |
| June 30, 2019 | 1.930B |
| March 31, 2019 | 1.575B |
| December 31, 2018 | 1.424B |
| September 30, 2018 | 1.226B |
| June 30, 2018 | 1.243B |
| March 31, 2018 | 1.334B |
| December 31, 2017 | 1.567B |
| September 30, 2017 | 1.817B |
| June 30, 2017 | 2.169B |
| March 31, 2017 | 2.051B |
| December 31, 2016 | 1.855B |
| September 30, 2016 | 1.849B |
| June 30, 2016 | 1.585B |
| March 31, 2016 | 1.653B |
| December 31, 2015 | 1.677B |
| September 30, 2015 | 2.264B |
| June 30, 2015 | 2.341B |
| March 31, 2015 | 2.530B |
| December 31, 2014 | 2.778B |
| September 30, 2014 | 1.981B |
| June 30, 2014 | 2.182B |
| March 31, 2014 | 2.144B |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| STRATEC SE | -- |
| Sartorius AG | 321.06M |
| Petros Pharmaceuticals, Inc. | -3.716M |
| Danaher Corp. | 5.466B |
| Illumina, Inc. | 511.00M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 706.85M |
| Cash from Investing (Quarterly) | -710.40M |
| Cash from Financing (Quarterly) | -920.17M |
| Free Cash Flow Per Share (Quarterly) | -0.2575 |
| Free Cash Flow to Equity (Quarterly) | -754.56M |
| Free Cash Flow to Firm (Quarterly) | -436.92M |
| Free Cash Flow Yield | 0.06% |